Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 28 February 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) announced 28 February that it intends to conduct a pilot evaluation program for a new electronic data standard format to support application reviews.
The new standard, developed by the Clinical Data Interchange Standards Consortium (CDISC), is known as the Standard for Exchange of Nonclinical Data (SEND).
"FDA believes the use of standardized SEND datasets, together with new and better analysis tools, will enhance CBER's review and evaluation of nonclinical data," said FDA in the Federal Register posting.
The pilot study should allow both industry and CBER to determine if the SEND standard assists or hinders the nonclinical study data submission process in investigational new drugs.
FDA notes that a "lack of uniformity in the formats used by sponsors to submit data [and] the inconsistent use of terminology across submissions complicates CBER's efforts to validate, display, and evaluate the data using modern computer-based review and analysis tools."
FDA - Electronic Submission of Nonclinical Study Data; Notice of Pilot Project
Tags: Nonclinical, CDISC, SEND, Pilot, electronic, IND, Latest News, data, study